In the past, medical devices, most people would think of hospital X-ray machines, nuclear magnetic resonance instruments, or scalpels and bandages. In fact, with the expansion of the chronic patient population, many new home medical devices will enter the homes of the people in the future. Household medical devices have not yet been popularized in China, but they have become commonplace in developed countries. The global market size increased from US$17.9 billion in 2010 to US$22.9 billion in 2014, with a compound annual growth rate of 6.7%, which is higher than the overall growth rate of 2.12% in the medical device industry and 3.81% in the pharmaceutical market. In 2010, the size of China's home medical market was 13.765 billion yuan. In 2014, the market size was 37.642 billion yuan. The compound annual growth rate in the past five years was 29.8%, which was higher than the 7.26% of the pharmaceutical industry and 11.70% of the medical device industry. The period of development. Due to the increasing aging, the number of patients with chronic diseases in China has been rising. At the same time, China's household consumption expenditures are growing at a rate of more than 15% per year. The improvement of consumption levels, changes in consumption structure, and advances in consumer awareness will stimulate the penetration of household medical devices. From the perspective of the path of medical system construction in developed regions, family medical care, rehabilitation and prevention have become an important part of the medical system. China's medical system is currently in the transition period from the second phase to the third phase. In the future, family prevention, medical care and rehabilitation will become the mainstream. China's home medical device industry will benefit from the construction of a sound medical system. Blood glucose monitoring systems, massage equipment, sphygmomanometers and hearing aids are the four main subcategories of home medical devices. The blood glucose monitoring system benefits from the rigid demand of 100 million diabetic patients, the industry growth rate reaches 20%, the current relative penetration rate is only 20%, far lower than 90% in developed countries, and the theoretical upside is large. The industry potential for massage equipment and sphygmomanometers is second. Hearing aids are limited in development due to lack of domestic fitting points and lack of professional service awareness, and they are difficult to solve in the short term. Specifically, the blood glucose monitoring system is expected to reach 10.27 billion yuan in 2020, and the prospects for cooperation between leading Chinese companies and international giants are expected. Based on the current domestic consumption level and the level of medical insurance coverage, the penetration rate of China's blood glucose monitoring system is expected to reach 55% in 2020, and the market size is about 10.27 billion yuan. The production of blood glucose test strips in the blood glucose monitoring system has a strong scale effect, and the sales volume has a positive correlation with the gross profit rate of the enterprise. The enterprises with high scale have obvious advantages. The domestic price difference monitoring products of the same price are not much different. The core competitiveness of each manufacturer in the OTC end is mainly reflected in the layout of the channel. From Bayer's sale of blood glucose business, it can be seen that the downward pressure on the price of blood glucose test strips caused by the strong bargaining power of US medical insurance has made it possible for Chinese companies to share some market share in the low-end field by cooperating with international giants. Massage equipment is expected to reach a market size of 24.17 billion yuan in 2020. Under the trend of domestic market export to domestic sales, brand building is the success of the company. With the increasing demand for massage and health care, the penetration rate of massage equipment in the Chinese market is expected to reach 25% in 2020, corresponding to a market size of 24.17 billion yuan. Under the trend that domestic demand is greater than export, the domestic market layout and brand strength are the vane of successful enterprises. The sphygmomanometer is expected to reach a market size of 24.17 billion yuan in 2020. The competition in the industry is fierce and the advantages of differentiation are highlighted. Omron is currently ranked first with 60% market share brand influence. With its advanced management and R&D capabilities, Omron has achieved a leap in its business in China through differentiated products, services and personnel. Differentiation is an important advantage of this fully competitive industry. Hearing aids have not yet been listed by listed companies. Only the subsidiaries of Hainan Haiyao produce cochlear implants, and medical device companies have the advantage of intervention. Driven by multiple factors such as economic development, rising income levels of residents, and changes in consumer attitudes, it is expected that by 2020, the market size of China's hearing aid industry will reach 5 billion yuan. Compared with foreign-funded and Sino-foreign joint ventures, domestic enterprises do not have the ability to compete on the scale. The patient's choice of hearing aid products will follow the doctor's advice and recommendations, and the company's involvement in this field requires hospital channel advantages. garden gloves,garden work gloves,work gloves for garden HOLIK ASIA GROUP CO.LTD , https://www.holikasia.com